Last time around, Trump withdrew the US from the Paris Agreement. For investors, there are risks and opportunities.
It’s that time of the year again: capital gains distribution season. Fund companies are required to give investors an idea of ...
I'm a member of a Facebook group in the Coachella Valley and someone posted a photo of the owner of a coffee shop supporting [name redacted] and asked people to boycott their business. Is this what ...
--Off 13.13% since the pre-Brexit vote level of 1.49 on Thursday, June 23, 2016 --Off 3.68% from its 52-week high of 1.3415 hit Tuesday, Sept. 24, 2024 --Up 5.68% from its 52-week low of 1.2227 hit ...
I have five children and I'm a mother in turmoil. One of my children has estranged herself from both me and her father. She has stated that, while raising her, we did not do anything wrong, but we ...
AppLovin's stock had its best day ever Thursday, rising 46% following the company's latest earnings, and it gained another 18% in Friday's session. That could reflect investor perception of how far ...
Houston plans to sell $1 billion of municipal bonds to help pay for construction and improvements at Terminal B of the at George Bush Intercontinental Airport, all of which will be installed and used ...
--Off 4.23% from its 52-week high of 1.1194 hit Friday, Aug. 23, 2024 --Up 0.95% from its 52-week low of 1.0619 hit Tuesday, April 16, 2024 --Rose 0.32% vs the dollar from 52 weeks ago --Month-to-date ...
Off 5.61% from its 52-week high of 161.697 hit Wednesday, July 10, 2024 --Up 8.55% from its 52-week low of 140.613 hit Monday, Sept 16, 2024 --Rose 0.73% vs the Japanese yen from 52 weeks ago ...
Health-care companies rose amid mixed earnings. Baxter International shares fell after it posted a drop in third-quarter earnings. Shares of cannabis producer Canopy Growth fell after a slowdown in ...
Communications services companies fell as traders digested earnings in the sector. Paramount Global shares fell as strength in its streaming revenue was offset by concerns about growth in its movie ...
Autolus Therapeutics said it received Food and Drug Administration approval of its treatment of acute lymphoblastic leukemia, or ALL, an aggressive blood and bone marrow cancer, for certain patients.